Debate. Percutaneous revascularization in dilated cardiomyopathy. Apropos of the REVIVED BCIS2 trial: the clinician’s view
QUESTION: What’s your interpretation of the REVIVED BCIS2 trial? Which, would you say, are its most positive and debatable features? ANSWER: The REVIVED BCIS21 trial randomized stable patients with ischemic dilated cardiomyopathy to undergo percutaneous coronary intervention (PCI) along w...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2023-11-01
|
| Series: | REC: Interventional Cardiology (English Ed.) |
| Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=1170 |